MDxHealth SA (MDXH) Misses Q3 EPS by 5c

MDxHealth SA (NASDAQ: MDXH) reported Q3 EPS of ($0.16), $0.05 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $28.12 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.

You May Also Be Interested In

• UBS Upgrades Allegiant Travel Company (ALGT) to Buy, 'Sell-Off Has Created a Compelling Opportunity'
• Ivonescimab cuts death risk 27% vs. pembrolizumab in lung cancer
• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy